Half of Long COVID Patients Experience Significant Recovery Within Three Years
Approximately 50.1% of patients with long COVID experienced sustained symptom improvement within three years of their initial infection.
Approximately 50.1% of patients with long COVID experienced sustained symptom improvement within three years of their initial infection.
The SV70 provides noninvasive ventilation and high-flow therapy while maintaining compatibility with existing hospital accessories.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
New RNA extraction techniques overcome barriers to help scientists better evaluate treatments for diseases such as pulmonary fibrosis.
A $20.7M federal grant will fund a 5-year inhaled vaccines initiative at the Icahn School of Medicine at Mount Sinai beginning with development of an avian influenza nasal spray prototype.
New virtual reality software from VRSim simulates emergency scene variables to prepare EMS teams for high-pressure field decisions.
Only about 18% of eligible US adults underwent lung cancer screening in 2022, lagging far behind rates for breast and colorectal cancer screenings.
The Inspire hypoglossal nerve stimulation device provides an alternative for eligible adolescents with Down syndrome who cannot tolerate CPAP.